CLINICAL_TRIALS
research
· 2017-08-16
Clinical Trial Update: Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer [Phase 2, Phase 3]
Summary
A clinical trial update describing intrabdominal hyperthermic chemotherapy for resectable pancreatic adenocarcinoma, spanning Phase 2 and Phase 3; the current s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospital General de Ciudad Real | Conditions: Resectable Pancreatic Adenocarcinoma | Phase 2, Phase 3 | Status: UNKNOWN